CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Daewon Pharmaceutical Co Ltd Company Snapshot
Daewon Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Daewon Pharmaceutical Co Ltd with three other companies in this sector in South Korea: Huons Co Ltd (2017 sales of 284.84 billion Korean Won [US$263.48 million] ), IL-Yang Pharmaceutical Company Limited (269.81 billion Korean Won [US$249.58 million] ), and Dong Wha Pharm Company Limited (258.88 billion Korean Won [US$239.47 million] ).

Sales Analysis. During the year ended December of 2017, sales at Daewon Pharmaceutical Co Ltd were 265.46 billion Korean Won (US$245.55 million). This is an increase of 10.3% versus 2016, when the company's sales were 240.72 billion Korean Won. This was the fifth consecutive year of sales increases at Daewon Pharmaceutical Co Ltd (and since 2012, sales have increased a total of 92%). Sales of Phamaceutical saw an increase of 10.4% in 2017, from 238.45 billion Korean Won to 263.36 billion Korean Won. Not all segments of Daewon Pharmaceutical Co Ltd experienced an increase in sales in 2017: sales of Hearing Aid fell 2.0% to 2.27 billion Korean Won. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Daewon Pharmaceutical Co Ltd
  Stock Performance Chart for Daewon Pharmaceutical Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (5/18/2018): 20,200
(Figures in Korean Won)
1 Week 1.5%   13 Weeks -4.7%  
4 Weeks -3.6%   52 Weeks 5.5%  
 
Daewon Pharmaceutical Co Ltd Key Data:
  Ticker: 003220 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 265,462,478,267
(Year Ending Jan 2018).
Employees: 741
  Currency: Korean Won Market Cap: 379,808,197,200
  Fiscal Yr Ends: December Shares Outstanding: 18,802,386
  Share Type: Common Closely Held Shares: 8,344,292
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.